During the 1.5 day meeting, members had the opportunity to network and discuss strategies in personalised medicine research funding. The European Commission informed about ongoing initiatives in the field of personalised medicine. The ICPerMed Secretariat reported on past and ongoing activities like the publication of the ICPerMed Action Plan, the set-up of the ICPerMed website and the organisation of future ICPerMed events.
Two high-level guest speakers were invited:
- Marisa Papaluca from the European Medicines Agency talked about “Status quo and future plans for regulatory actions in the field of personalised medicine”.
- Nathalie Seigneuret from the Innovative Medicines Initiative (IMI) talked about “The Strategic Research Agenda of IMI in the field of PM – opportunities and challenges of public-private-partnerships-driven PM research”.
Both talks inspired discussion and showed that there is a huge potential for synergies and collaboration that ICPerMed will follow up in the future.